Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

This study has been completed.
Sponsor:
Collaborators:
University of Oxford
Wellcome Trust
Information provided by:
European Malaria Vaccine Initiative
ClinicalTrials.gov Identifier:
NCT00374998
First received: September 10, 2006
Last updated: February 28, 2007
Last verified: February 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given